Decrease in in vivo coagulant potential of emicizumab in a patient with hemophilia A and inhibitor complicated with infectious mononucleosis : Blood Coagulation & Fibrinolysis

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Case report

Decrease in in vivo coagulant potential of emicizumab in a patient with hemophilia A and inhibitor complicated with infectious mononucleosis

Furukawa, Shokoa; Ogiwara, Kenichia; Yada, Kojia,b; Takeyama, Masahiroa; Niino, Tomomic; Shima, Midoria; Keiji, Nogamia

Author Information
Blood Coagulation & Fibrinolysis: November 08, 2022 - Volume - Issue - 10.1097/MBC.0000000000001177
doi: 10.1097/MBC.0000000000001177
  • Buy
  • PAP

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.